The global cosmetics regulatory environment continues to evolve. To help businesses stay updated with regulatory changes, ZMUni Compliance Center regularly releases a monthly recap of global cosmetics regulations. This article covers the regulatory developments related to cosmetics within China and globally in June 2025, with an emphasis on updates in cosmetic ingredients, cosmetic management, among others.
New Cosmetics Ingredients (NCI) Notification
In June 2025, 14 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA). They include:
The technical requirements for the 14 new cosmetic ingredients mentioned above have not been disclosed, and they have not yet entered the monitoring period.
Prior to this recap, ZMUni has continued to release passages introducing the NCI updates with its approval status and market applications, for more detailed information, check the following episodes:
China's NCI Approval Updates: 4 New Ingredients Notified Including Hydroxytyrosol and Postbiotics
China's NCI Approval Updates: Two Overseas Companies Involved
China's NCI Approval Updates: Botanee Notified Three Botanicals
Regulation Updates
On June 10, 2025, China's State Administration for Market Regulation (SAMR), in collaboration with the Cyberspace Administration of China (CAC), released the draft Administrative Measures for Supervision of Live-Stream E-commerce for public comment. The proposed regulation aims to further standardize market order, protect the legitimate rights and interests of all stakeholders, and promote the healthy development of the live-stream e-commerce sector. Comments are welcomed until July 10, 2025. See previous report.
On June 16, 2025, Macao issued Chief Executive's Order No. 109/2025, prohibiting the import, export, and transit of 14 mercury-added products listed under the Minamata Convention on Mercury and its related amendments. The ban includes certain cosmetics such as skin-lightening soaps and creams, while exempting eye-area cosmetics that use mercury as a preservative and lack effective and safe alternatives. The regulation will take effect on January 1, 2026.
On June 23, 2025, Taiwan Food and Drug Administration (TFDA) released the Guidelines on the Safe Use of Spray Cosmetics to enhance safety during the use and storage of spray-type cosmetic products. The document serves as an administrative guidance and may be referenced voluntarily by relevant stakeholders.
On June 24, 2025, China's National Institutes for Food and Drug Control (NIFDC) has released nine draft cosmetic standards for public consultation. These include the General Principles for Physicochemical Testing Methods, among others, and aim to further improving the cosmetic technical standards. The public consultation period will remain open until July 15, 2025. See previous report.
On June 24, 2025, China National Medical Products Administration (NMPA) issued an important announcement regarding significant adjustments for the Inventory of Existing Cosmetic Ingredient in China (IECIC). See previous report.
On June 24, 2025, China NIFDC released two trial guidelines for new cosmetic ingredients, including:
Guidelines for Research and Determination of Safe Use History of New Cosmetic Ingredients (Trial)
Guidelines for Research and Determination of Safe Consumption History of New Cosmetic Ingredients (Trial)
These Guidelines are accompanied by two Q&A documents that provide further interpretation and technical clarification. The release supports the implementation of the Several Provisions on Supporting Cosmetic Ingredient Innovation and strengthen technical guidance on the determination and classification of application situations for new cosmetic ingredient. See previous report.
Official FAQs
On June 17, 2025, China NMPA published the Cosmetic Supervision and Administration Q&A (VII), addressing several labeling and compliance issues that have drawn industry attention. The Q&A clarifies requirements for listing allergens introduced via ingredients such as fragrances and plant extracts on Chinese labels. It also specifies that products claiming to be "microcrystalline" or "microneedle" may fall outside the regulatory definition of cosmetics under the Cosmetics Supervision and Administration Regulation if, based on their formulation, usage method, and physical form, they are not intended for application on the human body surface.
In June 2024, the Guangzhou Medical Products Administration issued the 82nd and 83rd issues of the "FAQs on the Notification of General Cosmetics." Issue 82 is a re-post of the Cosmetic Supervision and Administration Q&A (VII) issued by China's NMPA. Issue 83 addresses practical concerns such as inconsistencies in full ingredient labeling and procedures for applying to deactivate user accounts of canceled registrants or notifiers entities.
On June 25, 2025, the Beijing Medical Products Administration issued "FAQs on the Notification of General Cosmetics" (Vol. 46), providing clarifications on frequently asked questions related to toothpaste product notifications, testing methods for cosmetic registration and notification, as well as analytical methods for detecting dioxane.
Non-compliant Imported Cosmetics
On June 19, 2025, the General Administration of Customs (GACC) published the List of Non-Compliant Imported Cosmetics for May 2025. A total of 10 batches of cosmetics were denied entry at border checkpoints due to non-compliance with safety and hygiene regulations. Among the rejected products:
8 batches failed due to non-compliant labeling,
1 batch was found to be past its expiration date,
1 batch had discrepancies between the goods and accompanying documents.
Europe
On June 6, 2025, the European Union's Scientific Committee on Consumer Safety (SCCS) released its preliminary opinion on Tea Tree Oil (CAS No. 68647-73-4) and launched a public consultation open until August 18, 2025. According to the SCCS, Tea Tree Oil is considered safe for use as an anti-seborrheic and anti-microbial agent at the following maximum concentrations: 2.0% in shampoos, 1.0% in shower gels and facial cleansers, 0.1% in face creams. The current safety assessment does not cover aerosol or spray-type products.
On June 6, 2025, SCCS issued a preliminary opinion (SCCS/1680/25) on three Prostaglandin Analogues (PGAs), launching a public consultation open until August 18, 2025. The three substances under assessment are: Methylamido-Dihydro-Noralfaprostal (MDN), Isopropyl Cloprostenate (IPCP) and Dechloro Dihydroxy Difluoro Ethylcloprostenolamide (DDDE). These substances are not currently listed in the annexes of the EU Cosmetics Regulation (EC) No. 1223/2009 and do not have established concentration limits for cosmetic use.
One June 30, SCCS issued three final opinions on UV filters, including:
America
On June 3, 2025, the U.S. House Committee on Energy and Commerce received a significant legislative proposal—The Supporting Accessible, Flexible, and Effective Sunscreen Standards Act (H.R. 3686), also known as the SAFE Sunscreen Standards Act. Led by Representative John Joyce (R-PA) and co-sponsored by lawmakers from multiple states, the bill seeks to amend the Federal Food, Drug, and Cosmetic Act. Its primary goal is to streamline and modernize the regulatory review process for the safety and efficacy of over-the-counter (OTC) sunscreen active ingredients.
Asia
On June 2, 2025, the Indonesian Food and Drug Supervisory Agency (BPOM) released a new draft regulation aimed at enhancing the safety and quality control of imported cosmetic products. The draft specifies mandatory test parameters that must be included in the Certificates of Analysis (CoA) submitted during the import certification process, marking a significant step toward more stringent regulatory oversight.
On June 19, 2025, South Korea's Ministry of Food and Drug Safety (MFDS) issued Notification No. 2025-258, announcing a proposed amendment to the Enforcement Rule of the Cosmetics Act. The amendment proposes enhanced regulation of cosmetics purchased directly from overseas, including risk information disclosure, mandatory testing, and consumer usage surveys. The public consultation period is open until July 30, 2025.
Note: This article is compiled by ZMUni Compliance Centre, drawing from the latest updates from official regulatory authorities in various countries and regions. For any questions regarding interpretations or expressions, please consult the official real-time announcements.